跳至主要内容
临床试验/ACTRN12612001124820
ACTRN12612001124820已完成未知

Topical Platelet Derived Growth Factor (PDGF) Regranex Shows Equivalent Rate of Healing to Placebo for Diabetic Foot Ulcers Off-loaded with Windowed Casts

Heritage Provider Network, Inc0 个研究点目标入组 46 人开始时间: 2012年10月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
Male

入选标准

  • Wagner Grade 1 Diabetic Foot Ulcer, ulcer area between 1-16 square centimerters

排除标准

  • Wagner Grade 2 ulcer or above, osteomyelitis or infection requiring antibiotics, ulcer area outside of range 1-16 square centimeters, more then two full thickness wounds on the involved extremity, moderate to severe peripheral arterial disease (ABI < 0.7), concomitant use of Pletal (cilostazol), inability to tolerate casting or unsteady gait, active neoplasia, concomitant steroid use, chronic alcohol or drug abuse

研究者

发起方
Heritage Provider Network, Inc

相似试验

Topical Platelet Derived Growth Factor (PDGF) Versus... | 临床试验